Skip to content

Consumption of Chocolate in Pregnant Women.

Consumption of Chocolate in Pregnant Women at High Risk for Preeclampsia.

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01431443
Acronym
CHOCENTA
Enrollment
160
Registered
2011-09-09
Start date
2011-05-31
Completion date
2014-09-30
Last updated
2015-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Keywords

Randomized double blind trial, Cocoa flavonoids, Endothelial function, Blood pressure, Pregnant women, Preeclampsia, Uterine artery flow, Pulsatility index

Brief summary

The purpose of this study is to investigate the acute and chronic effect of consumption of flavanol-rich chocolate on endothelium function in pregnant women at high risk for preeclampsia.

Detailed description

Although numerous strategies have been studied, no effective prevention or treatment of preeclampsia is yet available for pregnant women. This is surprising considering the growing body of literature that supports the hypothesis of a beneficial effect of dark chocolate consumption through the activity of flavanols on the endothelial function and blood pressure regulation, to find any clinical data among pregnant women with preeclampsia. The primary objective of the trial is to investigate the acute and chronic effect of consumption of flavanol-rich chocolate on endothelial function in pregnant women at high risk of preeclampsia. This 12-week efficacy study will permit us to verify the sustainability of the effect of daily intake of flavanol-rich chocolate intake.

Interventions

The aim of this study is to evaluate the beneficial effect of dark chocolate consumption through the activity of flavanols on the endothelial function and blood pressure regulation, in acute (after 3 hours) and chronic effect (12 weeks), among pregnant women at high risk for preeclampsia.

Placebo intervention

Sponsors

Laval University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Pregnant women between the ages of 18 and 40 years. * Presence of uterine diastolic notches measured by uterine artery Doppler between 10 and 14 weeks.

Exclusion criteria

* Hypertension requiring medication. * Currently or previously use of medications interfering with glucose or lipids metabolism. * Use of supplements or natural health products that interfere with blood pressure. * Consumption of 1 or more alcohol drink per day. * Allergy or intolerance to nuts or chocolate.

Design outcomes

Primary

MeasureTime frame
Changes in endothelial functionwithin the first 12 weeks of chocolate intake

Secondary

MeasureTime frameDescription
Doppler of uterine arterieswithin the first 12 weeks of chocolate intake
Blood pressurewithin the first 12 weeks of chocolate intake
Plasma biomarker of endothelium functionwithin the first 12 weeks of chocolate intake
Plasma biomarker of chocolate intakewithin the first 12 weeks of chocolate intakeng\\ml plasma

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026